Personalized Medicine as Innovation

What Can Germany Learn from the USA
1. Auflage 2019
ISBN: 978-3-658-27842-7
Verlag: Springer

Buch, Englisch, 354 Seiten, Paperback, Format (B × H): 148 mm x 210 mm, Gewicht: 491 g

Reihe: Research

Katharina Kichko supports the first Personalized Medicine learnings as she provides an approach overview in general as well as reimbursement and regulatory policies in particular. In focus stays analysis of the current Personalized Medicine in the U.S. and Germany as well as its preconditions for a wider implementation in the medical practice. Results have shown that the U.S. – as early knower – have the most projects as well as personalized drugs and therapies, while Germany – as a follower – has a significant number of projects and personalized products and more to come in future.

Zielgruppe

Research

Autoren/Hrsg.

Kichko, Katharina

Fachgebiete

• Wirtschaftswissenschaften Volkswirtschaftslehre Gesundheitsökonomie
• Wirtschaftswissenschaften Betriebswirtschaft Management Forschung & Entwicklung (F&E), Innovation
• Medizin | Veterinärmedizin Medizin | Public Health | Pharmazie | Zahnmedizin Medizin, Gesundheitswesen Public Health, Gesundheitsmanagement, Gesundheitsökonomie, Gesundheitspolitik

Inhaltsverzeichnis

Personalized Medicine Background.- The United States of America as Early Knower.- Germany as Follower.- Further Implementation of Personalized Medicine in Germany Based on Learnings from the U.S.

Über Autor(innen)

Katharina Kichko has written this book within her PhD program at the University of Greifswald.